Anifrolumab vs Dapagliflozin

## Anifrolumab vs Dapagliflozin: Overview

This comparison examines the pharmacological differences between **Anifrolumab** and **Dapagliflozin**.

## Mechanism of Action

**Dapagliflozin**: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

## Pharmacokinetics

**Half-life**: Anifrolumab — N/A; Dapagliflozin — 12.9 hours.

## Chemical Properties

**Molecular Formula**: Anifrolumab — N/A; Dapagliflozin — C21H25ClO6.

**Molecular Weight**: Anifrolumab — N/A; Dapagliflozin — 408.8730 g/mol.

**Type**: Anifrolumab — Antibody; Dapagliflozin — Small molecule.